Five - Year Extended Hormone Therapy No Better in Breast Cancer
Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone - receptor - positive breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Pharmacy, Journal, Source Type: news
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Pathology | Women